Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All case investigation)

Trial Identifier: D9603C00001
Sponsor: AstraZeneca
Start Date: June 2022
Primary Completion Date: November 2025
Study Completion Date: November 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aomori, Japan
Japan Ehime, Japan
Japan Fukushima, Japan
Japan Gunma, Japan
Japan Ishikawa, Japan
Japan Iwate, Japan
Japan Kagawa, Japan
Japan Kochi, Japan
Japan Nagano, Japan
Japan Nagasaki, Japan
Japan Nara, Japan
Japan Saga, Japan
Japan Saitama, Japan
Japan Tottori, Japan
Japan Toyama, Japan
Japan Yamagata, Japan
Japan Yamaguchi, Japan